Colulintide
Highest phase reached
Phase 1
Drug type
Protein
- Listing at source
- Listed
- Highest phase reached
- Phase 1
- Drug type
- Protein
- Drug name
- Colulintide
- colulintide
- Colulintide
- colulintide [INN]
- colulintide inn
- ly 3541105
- LY-3541105
- ly3541105
- Ly3541105
- LY3541105
- CAS registry numbers
- 2891912-36-8
- ChEMBL ID
- CHEMBL6068472
- FDA ingredient codes (UNII)
- KX23AY2A39
- First in class
- No
- Orphan designation
- No
- Drug name stem
- -tide
Investigated indications
- Condition
- Obesity
- Highest recorded phase
- 1
- Condition identifier
- EFO:0001073
- Subject identifier
- D009765
- Condition identifier
- EFO_0001073
- Highest recorded phase
- 1
- Condition identifier
- HP_0001513
- Highest recorded phase
- 1
- Condition identifier
- HP_0025502
- Highest recorded phase
- 1
- Condition identifier
- MONDO_0011122
Trial references
- NCT05380323
- Prodrug
- No
- Chirality
- Single enantiomer
- Inorganic
- No
- Natural product
- No
Related records
Trials (1)
In development for (1)
- Obesity disorder Phase 1